v3.25.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Research and development expenses    
Expenses incurred $ 1,178 $ 2,061
Less- government grants (468)
Research and development expenses, net 710 2,061
Marketing expenses 220 822
General and administrative expenses 1,011 2,028
Total operating loss 1,941 4,911
Other income (48)
Financial expenses (income), net 6 (2)
Loss for the year $ 1,899 $ 4,909
Loss per share    
Basic loss per common stock $ (0.03) $ (0.07)
Dilutive loss per common stock $ (0.03) $ (0.07)

Source